Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Eur J Med Chem. 2013 May;63:33-45. doi: 10.1016/j.ejmech.2012.12.061. Epub 2013 Feb 13.
A new series of 2-heteroarylthio-6-substituted-quinazolin-4-one analogs was designed, synthesized, and evaluated for their in vitro DHFR inhibition, antimicrobial, and antitumor activities. Compounds 21, 25, and 39 proved to be active DHFR inhibitors with IC50 range of 0.3-0.8 μM. Compounds 25, 28, 33, 35 and 36 showed broad spectrum antimicrobial activity comparable to the known antibiotic gentamicin. Compound 29 showed broad spectrum antitumor activity toward several tumor cell lines with GI values range of 25.8-41.2%. Molecular modeling studies concluded that recognition with key amino acid Arg38 and Lys31 are essential for binding and biological activities. Flexible alignment; electrostatic and hydrophobic mappings revealed that the obtained model could be useful for the development of new DHFR inhibitors.
设计、合成了一系列新型 2-杂芳基硫代-6-取代喹唑啉-4(3H)-酮类似物,并对其体外二氢叶酸还原酶(DHFR)抑制、抗菌和抗肿瘤活性进行了评价。化合物 21、25 和 39 被证明是具有 IC50 为 0.3-0.8 μM 的活性 DHFR 抑制剂。化合物 25、28、33、35 和 36 表现出广谱抗菌活性,与已知抗生素庆大霉素相当。化合物 29 对几种肿瘤细胞系表现出广谱抗肿瘤活性,GI 值范围为 25.8-41.2%。分子模拟研究表明,与关键氨基酸 Arg38 和 Lys31 的识别对于结合和生物活性是必需的。柔性对齐;静电和疏水性映射表明,获得的模型可用于开发新的 DHFR 抑制剂。